A COMPARISON OF THE SEDATIVE, HEMODYNAMIC, AND RESPIRATORY EFFECTS OF DEXMEDETOMIDINE AND PROPOFOL IN CHILDREN UNDERGOING MAGNETIC RESONANCE IMAGING

Dr Chandrasekhar Krishnamurti

Abstract


Sedation of children for MRI is usually associated with inadequate or failed sedation because of difficulty in achieving complete immobility while maintaining hemodynamic and respiratory stability.

30 children each in two groups Group D receiving intravenous (iv) dexmedetomidine a potent, highly selective α2adrenoreceptor agonist and Group P receiving iv propofol were compared for efficacy in MRI sedation.

Dexmedetomidine was effective in 78.5% of cases with 21.5% of children required additional medications. Side effects occurred in approximately 25% of cases, bradycardia (3.9%) and hypotension (18.4%) that resolved spontaneously. In group P, the onset of sedation, recovery, and discharge time were significantly shorter than in group D (P< 0.05). The level of consciousness was the same in both groups at the time of discharge. The duration of drug infusion was not different between groups (P> 0.05).

100% of the children in both treatments completed their MRI scans without interruption or interventions (i.e., no failures) and without complications. Heart rate and systolic blood pressure changes were transient and statistically significant, but not of sufficient magnitude to warrant interventions.


Keywords


MRI, sedation, pediatric

Full Text:

PDF

References


Lawson GR. Sedation of children for magnetic resonance imaging. Arch Dis Child 2000;82:150–2.

Hasan RA, Shayevitz JR, Patel V. Deep sedation with propofol for children undergoing ambulatory magnetic resonance imaging of the brain: Experience from a pediatric intensive care unit. PediatrCrit Care Med 2003;4:454–8

Bluemke DA, Breiter SN. Sedation procedures in MR imaging: safety, effectiveness, and nursing effect on examinations. Radiology 2000;216:645–52.

Malviya S, Voepel LT, Eldevik OP, et al. Sedation and general anaesthesia in children undergoing MRI and CT: adverse events and outcomes. Br J Anaesth 2000;84:743–8.

Dial S, Silver P, Bock K, Sagy M. Pediatric sedation for procedures titrated to desired degree of immobility results in unpredictable depth of sedation. Pediatr Emerg Care 2001;17:414–20.

Bhana KNL, McClellan GJ, McClellan KJ. Dexmedetomidine. Drugs 2000;59:263–8.

Shelly MP. Dexmedetomidine: a real innovation or more of the same? Br J Anaesth 2001;87:677–8

Nelson LE, Lu J, Guo T, et al. The alpha2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects. Anesthesiology 2003;98:428–36.

Koroglu A, Demirbilek S, Teksan H, et al. Sedative, hemodynamic and respiratory effects of dexmedetomidine in children undergoing magnetic resonance imaging examination: preliminary results. Br J Anaesth 2005;94:821–4.

Frankville DD, Spear RM, Dyck JB. The dose of propofol required to prevent children from moving during magnetic resonance imaging. Anesthesiology 1993;79:953–8.

Usher GA, Kearney RA, Tsui BCH. Propofol total intravenous anesthesia for MRI in children. Paediatr Anaesth 2005;15:23–8.

Frankville DD, Spear RM, Dyck JB. The dose of propofol required to prevent children from moving during magnetic resonance imaging. Anesthesiology 1993;79:953–8.

Petroz GC, Sikich N, James M, van Dyk H, Shafer SL, Schily M, Lerman J. A phase 1, two-center study of the pharmacokinetics and pharmacodynamics of dexmedetomidine in children. Anesthesiology 2006;105:1098–110

Voepel LT, Malviya S, Prochaska G, Tait RA. Sedation failures in children undergoing MRI and CT: is temperament a factor? Paediatr Anaesth 2000;10:319–23.

Hall JE, Ulrich TD, Barney JA, et al. Sedative, amnestic and analgesic properties of small-dose dexmedetomidine infusions. AnesthAnalg 2000;90:699–705.

Tobias JD, Berkenbosch JW. Initial experience with dexmedetomidine in paediatric-aged patients. Paediatr Anaesth 2002;12:171–5.

Tobias JD, Berkenbosch JW, Russo P. Additional experience with dexmedetomidine in pediatric patients. South Med J 2003;96:871–5.

Triltsch AE, Welte M, Von Homeyer P, et al. Bispectral index-guided sedation with dexmedetomidine in intensive care: randomized, double blind, placebo-controlled phase II study. Crit Care Med 2002;30:1007–14.

Usher GA, Kearney RA, Tsui BCH. Propofol total intravenous anesthesia for MRI in children. Paediatr Anaesth 2005;15:23–8.

Bloomfield EL, Masaryk TJ, Caplin A, et al. Intravenous sedation for MR imaging of the brain and spine in children: pentobarbital versus propofol. Pediatr Radiol 1993;186:93–7.

Kallio A, Scheinin M, Koulu M, et al. Effects of dexmedetomidine, a selective alpha2-adrenoceptor agonist, on hemodynamic control mechanisms. Clin Pharmacol Ther 1989;49:33–42.

Aun CS. New i.v. agents. Br J Anaesth 1999;83:29–41.

Tramer MR, Moore RA, McQuay HJ. Propofol and bradycardia: causation, frequency and severity. Br J Anaesth 1997;78:642–51.

Venn RM, Hell J, Grounds RM. Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care. Crit Care 2000;4:302–8.

Belleville JP, Wards DS, Bloor BC, Maze M. Effects of intravenous dexmedetomidine in human: sedation, ventilation and metabolic rate. Anesthesiology 1992;77:1125–33.


Refbacks

  • There are currently no refbacks.